The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer
Abstract Effective drugs are needed for lung cancer, as this disease remains the leading cause of cancer-related deaths. Rexinoids are promising drug candidates for cancer therapy because of their ability to modulate genes involved in inflammation, cell proliferation or differentiation, and apoptosi...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/6d8fd743dcf44e9bbf89c3d1f8bcd6a9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|